Showing 1 to 1 of 1 results
foxnews.com
🌐 85% Global Worthiness


New Glioblastoma Therapy Shows Promise in Clinical Trial
A New Jersey woman, Pamela Goldberger, 65, diagnosed with glioblastoma in 2023, is alive and healthy 2.5 years later after participating in a clinical trial for a new individualized dendritic cell therapy (DOC1021), showing promising results for this aggressive cancer.
New Glioblastoma Therapy Shows Promise in Clinical Trial
A New Jersey woman, Pamela Goldberger, 65, diagnosed with glioblastoma in 2023, is alive and healthy 2.5 years later after participating in a clinical trial for a new individualized dendritic cell therapy (DOC1021), showing promising results for this aggressive cancer.
Progress
40% Bias Score
Good Health and Well-being
Showing 1 to 1 of 1 results